These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 37206213)

  • 1. Biomimetic nanotherapeutics for targeted drug delivery to glioblastoma multiforme.
    Lim XY; Capinpin SM; Bolem N; Foo ASC; Yip WG; Kumar AP; Teh DBL
    Bioeng Transl Med; 2023 May; 8(3):e10483. PubMed ID: 37206213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug delivery approaches for the treatment of glioblastoma multiforme.
    Fakhoury M
    Artif Cells Nanomed Biotechnol; 2016 Sep; 44(6):1365-73. PubMed ID: 26046399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine Kinase Inhibitors for Glioblastoma Multiforme: Challenges and Opportunities for Drug Delivery.
    Brar HK; Jose J; Wu Z; Sharma M
    Pharmaceutics; 2022 Dec; 15(1):. PubMed ID: 36678688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticle-Based Combinational Strategies for Overcoming the Blood-Brain Barrier and Blood-Tumor Barrier.
    Lim SH; Yee GT; Khang D
    Int J Nanomedicine; 2024; 19():2529-2552. PubMed ID: 38505170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of Therapies for Glioblastoma (GBM) Using Nanoparticle-based Delivery Systems.
    Wiwatchaitawee K; Quarterman JC; Geary SM; Salem AK
    AAPS PharmSciTech; 2021 Feb; 22(2):71. PubMed ID: 33575970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotechnology for Treatment of Glioblastoma Multiforme.
    Michael JS; Lee BS; Zhang M; Yu JS
    J Transl Int Med; 2018 Sep; 6(3):128-133. PubMed ID: 30425948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in targeted drug delivery for the treatment of glioblastoma.
    Mao M; Wu Y; He Q
    Nanoscale; 2024 May; 16(18):8689-8707. PubMed ID: 38606460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanotechnology and Nanocarrier-Based Drug Delivery as the Potential Therapeutic Strategy for Glioblastoma Multiforme: An Update.
    Hsu JF; Chu SM; Liao CC; Wang CJ; Wang YS; Lai MY; Wang HC; Huang HR; Tsai MH
    Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33430494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CPP-Based Bioactive Drug Delivery to Penetrate the Blood-Brain Barrier: A Potential Therapy for Glioblastoma Multiforme.
    Mehdipour G; Wintrasiri MN; Ghasemi S
    Curr Drug Targets; 2022; 23(7):719-728. PubMed ID: 35142277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted Vascular Drug Delivery in Cerebral Cancer.
    Humle N; Johnsen KB; Arendt GA; Nielsen RP; Moos T; Thomsen LB
    Curr Pharm Des; 2016; 22(35):5487-5504. PubMed ID: 27464719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced biomaterials for human glioblastoma multiforme (GBM) drug delivery.
    Nozhat Z; Heydarzadeh S; Shahriari-Khalaji M; Wang S; Iqbal MZ; Kong X
    Biomater Sci; 2023 Jun; 11(12):4094-4131. PubMed ID: 37073998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery across the blood-brain barrier: nanomedicine for glioblastoma multiforme.
    Jena L; McErlean E; McCarthy H
    Drug Deliv Transl Res; 2020 Apr; 10(2):304-318. PubMed ID: 31728942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-ligand functionalized blood-to-tumor sequential targeting strategies in the field of glioblastoma nanomedicine.
    Martins C; Sarmento B
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(5):e1893. PubMed ID: 37186374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classical Monocytes Shuttling for Precise Delivery of Nanotherapeutics to Glioblastoma.
    Li C; Niu C; Chen L; Yu B; Luo F; Qie J; Yang H; Qian J; Chu Y
    Adv Healthc Mater; 2024 Aug; ():e2400925. PubMed ID: 39212635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Advancements and Strategies for Overcoming the Blood-Brain Barrier Using Albumin-Based Drug Delivery Systems to Treat Brain Cancer, with a Focus on Glioblastoma.
    Tincu Iurciuc CE; Andrițoiu CV; Popa M; Ochiuz L
    Polymers (Basel); 2023 Oct; 15(19):. PubMed ID: 37836018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
    van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
    Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The brilliance of nanoscience over cancer therapy: Novel promising nanotechnology-based methods for eradicating glioblastoma.
    Shabani L; Abbasi M; Amini M; Amani AM; Vaez A
    J Neurol Sci; 2022 Sep; 440():120316. PubMed ID: 35777316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in biomimetic strategies for the immunotherapy of glioblastoma.
    You H; Geng S; Li S; Imani M; Brambilla D; Sun T; Jiang C
    Biomaterials; 2024 Dec; 311():122694. PubMed ID: 38959533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanotechnology meets glioblastoma multiforme: Emerging therapeutic strategies.
    Liu D; Dai X; Ye L; Wang H; Qian H; Cheng H; Wang X
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023 Jan; 15(1):e1838. PubMed ID: 35959642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Near Infrared-Activatable Biomimetic Nanoplatform for Tumor-Specific Drug Release, Penetration and Chemo-Photothermal Synergistic Therapy of Orthotopic Glioblastoma.
    Li M; Zhang X; Zhou Y; Chu Y; Shen J; Cai Y; Sun X
    Int J Nanomedicine; 2024; 19():6999-7014. PubMed ID: 39011386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.